...
首页> 外文期刊>Powder Technology: An International Journal on the Science and Technology of Wet and Dry Particulate Systems >Preparation of novel optimum liquisolid compacts via incorporating water granulation process to enhance the powder characterizations and dissolution behavior of a poorly soluble drug: Norfloxacin
【24h】

Preparation of novel optimum liquisolid compacts via incorporating water granulation process to enhance the powder characterizations and dissolution behavior of a poorly soluble drug: Norfloxacin

机译:通过掺入水造粒工艺的新型最佳液质胶质块的制备,增强一种难以溶于药物的粉末表征和溶解行为:NORFLOXACIN

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this work is to investigate the addition of wet granulation technique into liquisolid process in order to enhance the characterizations of liquisolid compacts, such as flowability, compressibility and the percentage of drug release (using norfloxacin as a model of poorly soluble-permeable drug) in neutral dissolution medium. The water in the liquisolid formulations works as a liquid binder to the carrier and coating particles, creating a wider space inside their structure, which allows the amount of the liquid vehicle (PEG200 or Synperonic (TM) PE/L-61) to increase inside the formulations. This feature reflects positively on: the flowability (decreasing the angle of the slide up to 10 degrees), the compressibility (increasing the load factor from 0.2 to >0.4 in PEG200 liquisolid compacts and from 0.14 to 0.29 in the case of Synperonic (TM) PE/L-61iquisolid compacts) and the dissolution behaviour of norfloxacin (increasing drug release). The applied accelerated stability study on the water granulated liquisolid compacts showed no significant differences in the dissolution profiles. Also, the DSC thermographs indicated that the water granulated liquisolid compacts resist the applied stressful conditions. As a consequence, the positive outcomes of the combination between liquisolid and water granulation process open the door for robust tablet production on a large scale in pharmaceutical industries. (C) 2019 Elsevier B.V. All rights reserved.
机译:这项工作的目的是研究将湿法造粒技术的添加到液质过程中,以增强液质胶质块的表征,例如流动性,压缩性和药物释放的百分比(使用NORFLOXACIN作为可易透过的药物不良的模型)在中性溶解培养基中。液质制剂中的水作为载体和涂料颗粒的液体粘合剂作用,在其结构内部产生更宽的空间,这允许液体载体(PEG200或Synperonic(TM)PE / L-61)的量增加配方。该特性积极反映:流动性(将载玻片的角度降低至10度),压缩性(将载荷因子增加0.2至> 0.4,在PEG200 Liquisolid Compacts中,在Synperonic(TM)的情况下为0.14至0.29 PE / L-61喹啉块)和诺氟沙星的溶解行为(增加药物释放)。水造粒液质胶质块的应用加速稳定性研究显示出溶出型材的显着差异。而且,DSC温度计表示水粒状液质胶质块抵抗施加的施加压力条件。因此,在制药行业的大规模中,岩浆和水造粒工艺组合的阳性结果为强大的平板电脑生产。 (c)2019年Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号